SCHEMBL3846676

SCHEMBL3846676

Cc1cc(-c2cn(C(c3ccccc3)(c3ccccc3)c3ccccc3)nc2-c2ccc(F)cc2)cn2ccnc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CDK1 P06493 1/20 0.35
CDK4 P11802 1/20 0.35
CCNB1 P14635 1/20 0.35
CCNA2 P20248 1/20 0.35
CCND1 P24385 1/20 0.35
CDK2 P24941 1/20 0.35
CDK7 P50613 1/20 0.35
CCNH P51946 1/20 0.35
CSNK1D P48730 4/20 0.35
CSNK1E P49674 4/20 0.35
MAPK13 O15264 2/20 0.35
MAPK12 P53778 2/20 0.35
MAPK11 Q15759 2/20 0.35
MAPK14 Q16539 2/20 0.35
BRAF P15056 4/20 0.34
RAF1 P04049 3/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3849569 0.90 CDK1 (0.36) ADORA2ACDK1CDK4CCNB1CCNA2
SCHEMBL3850113 0.88 SMN1; SMN2 (0.38) ADORA2ACDK1CDK4CCNB1CCNA2
SCHEMBL3846680 0.83 ADORA2A (0.30) ADORA2ABRAFRAF1
SCHEMBL3845543 0.82 TGFBR1 (0.47) ADORA2ABRAFTGFBR1SRCKDR
SCHEMBL3846702 0.82 RORC (0.39) ADORA2ACSNK1DCSNK1EMAPK13MAPK12
SCHEMBL3848664 0.80 PTGS2 (0.32) CDK1CDK4CCNB1CCNA2CCND1
SCHEMBL3849827 0.78 TGFBR1 (0.39) ADORA2AMAPK13MAPK12MAPK11MAPK14
SCHEMBL3847154 0.77 KDR (0.37) CSNK1DCSNK1EMAPK13MAPK12MAPK11
SCHEMBL3849572 0.74 CDK1 (0.30) CDK1CDK4CCNB1CCNA2CCND1
SCHEMBL3850115 0.73 SMN1; SMN2 (0.32) BRAFNPC1NFKB1RAB9ANFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed